240 related articles for article (PubMed ID: 17002922)
1. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
[TBL] [Abstract][Full Text] [Related]
2. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
3. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH
Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892
[TBL] [Abstract][Full Text] [Related]
5. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
McLaren CE; Barton JC; Eckfeldt JH; McLaren GD; Acton RT; Adams PC; Henkin LF; Gordeuk VR; Vulpe CD; Harris EL; Harrison BW; Reiss JA; Snively BM
Am J Hematol; 2010 Feb; 85(2):101-5. PubMed ID: 20095037
[TBL] [Abstract][Full Text] [Related]
6. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
Adams PC
Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
[TBL] [Abstract][Full Text] [Related]
10. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
11. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
[TBL] [Abstract][Full Text] [Related]
12. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
McLaren GD; Gordeuk VR
Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
[TBL] [Abstract][Full Text] [Related]
13. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
[TBL] [Abstract][Full Text] [Related]
14. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
[TBL] [Abstract][Full Text] [Related]
15. Relation between HFE mutations and mild iron-overload expression.
Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
[TBL] [Abstract][Full Text] [Related]
16. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
17. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
[TBL] [Abstract][Full Text] [Related]
18. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
Lim A; Speechley M; Adams PC
Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357
[TBL] [Abstract][Full Text] [Related]
19. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
Acton RT; Barton JC; Snively BM; McLaren CE; Adams PC; Harris EL; Speechley MR; McLaren GD; Dawkins FW; Leiendecker-Foster C; Holup JL; Balasubramanyam A;
Ethn Dis; 2006; 16(4):815-21. PubMed ID: 17061732
[TBL] [Abstract][Full Text] [Related]
20. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
